Shopping Cart
- Remove All
Your shopping cart is currently empty
(170)
By Target- Apoptosis
- Autophagy(70)
- COX(31)
- DNA/RNA Synthesis(27)
- EGFR(27)
- NF-κB(43)
- PI3K(31)
- TNF(65)
- VEGFR(25)
- Others(1382)
Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Croatia
Cyprus
Czech
Denmark
Egypt
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Korea
Latvia
Lebanon
Malaysia
Malta
Morocco
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Singapore
Slovakia
Slovenia
Spain
Sweden
Switzerland
Taiwan,China
Thailand
Turkey
United Kingdom
United States
Other Countries
Select your Country or Region
Filter
Applied FilterClear all
By Target By ResearchField- Anti-infective(1)
- Cardiovascular disease(2)
- Inflammation and immunity(2)
- Metabolic diseases(3)
- Tumor/Cancer(8)
Filter
Search Result
Results for "tumor" in TargetMol Product Catalog
- Inhibitor Products2357
- Recombinant Protein819
- Natural Products438
- Peptides Products124
- Inhibitory Antibodies103
- PROTAC Products51
- Compound Libraries23
- Isotope products21
- Dye Reagents15
Anti-Tumor Natural Product Library
Cited
L6700
A unique collection of xnum natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
- $34,750
Size
QTY
CitedHuman Endogenous Metabolite Compound Library Plus
Cited
L2501
A unique collection of xnum endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.
- $20,280
Size
QTY
CitedAnti-Cancer Compound Library Cited
L2100
A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
- $94,750
Size
QTY
CitedHuman Endogenous Metabolite Library Cited
L2500
A collection of xnum selected human endogenous metabolites for high throughput and high content screening.
- $13,560
Size
QTY
CitedFlavonoid Natural Product Library Cited
L6120
A unique collection of xnum flavonoids can be used for high throughput and high content screening；
- $14,810
Size
QTY
CitedProtease Inhibitor Library Cited
L1100
A unique collection of xnum protease and proteasome inhibitors for research in chemical genomics, and drug screening;
- $12,360
Size
QTY
CitedAnti-Cancer Metabolism Compound Library Cited
L2130
A unique collection of xnum cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
- $27,040
Size
QTY
CitedNucleotide Compound Library Cited
L1720
A unique collection of xnum nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
- $8,620
Size
QTY
CitedImmuno-Oncology Compound Library Cited
L2170
A unique collection of xnum compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；
- $11,110
Size
QTY
CitedAnti-Cancer Active Compound Library Cited
L2160
A unique collection of xnum compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
- $56,480
Size
QTY
CitedGlycometabolism Compound Library Cited
L2520
xnum glycometabolism-related comounds, can be used for HTS and HCT;
- $18,210
Size
QTY
CitedPI3K-AKT-mTOR Compound Library Cited
L1300
A unique collection of xnum compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
- $17,100
Size
QTY
CitedTargeted Therapy Drug Library Cited
L2152
xnum tumor-targeted drugs that can be used for high-throughput and high-content screening.
- $2,920
Size
QTY
CitedCancer Cell Differentiation Compound Library Cited
L2140
A unique collection of xnum cancer cell differentiation inducing compounds for high throughput and high content screening;
- $9,730
Size
QTY
CitedPBCRBS Traditional Chinese Medicine Compound Library Cited
L6750
A unique collection of xnum compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.
- $16,280
Size
QTY
CitedTyrosine Kinase Inhibitor Library Cited
L2200
A unique collection of xnum tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
- $26,380
Size
QTY
CitedImmunology/Inflammation Compound Library Cited
L4700
A unique collection of xnum anti-inflammation compounds effective for high throughput screening and high content screening.
- $70,630
Size
QTY
CitedChemokine Inhibitor Library Cited
L7600
A unique collection of xnum chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
- $4,800
Size
QTY
CitedAngiogenesis related Compound Library Cited
L4800
A unique collection of xnum proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
- $36,910
Size
QTY
CitedAnti-Cancer Drug Library Cited
L2150
A unique collection of xnum anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
- $55,460
Size
QTY
CitedHIF-1 Signaling Pathway Compound Library Cited
L8500
A unique collection of xnum HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；
- $28,410
Size
QTY
CitedJAK-STAT Compound Library Cited
L3700
A unique collection of xnum JAK/STAT signaling targeted compounds for high throughput and high content screening;
- $6,480
Size
QTY
CitedAnti-Cancer Compound Library Plus Cited
L2180
Well-chosen xnum anti-tumor compounds with unique structures;
- $36,250
Size
QTY
Cited Go to page 1
Page of 1
Product Comparison
| Product |
|---|
| Species |
| Expression System |
| Tag |
| Accession Number |
| Amino Acid |
| Construction |
| Molecular Weight |
| Endotoxin |
| Formulation |
| Reconstitution |
| Stability & Storage |
| Shipping |
| Research Background |
| Size |
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.